News
-
-
COMMUNIQUÉ DE PRESSE
There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate
NanoViricides, Inc. announces advancing lead candidate NV-387 into Phase II clinical development for MPox. Protocol development and site addition underway in the DRC. Focus on antiviral drug against MPox/Smallpox -
-
COMMUNIQUÉ DE PRESSE
Market analysis by Kirchhoff and CMS: Every fourth company in the DAX160 voluntarily publishes preliminary figures
Market analysis by Kirchhoff Consult and CMS reveals that 1 in 4 DAX160 companies voluntarily release preliminary financial figures, posing legal risks and transparency challenges. Recommendations for communication and legal protection provided -
-
-
-
COMMUNIQUÉ DE PRESSE
comdirect relies on tick Trading Software AG for ProTrader: New generation of trading software for active retail traders
tick Trading Software AG collaborates with comdirect to launch ProTrader, a new trading software for active retail traders, offering user-friendly and reliable features -
COMMUNIQUÉ DE PRESSE
Affluent Medical : Affluent Medical met en lumière les avancées cliniques et réglementaires de son dispositif médical innovant Artus dans une interview exclusive sur Boursorama
Affluent Medical met en lumière les avancées cliniques et réglementaires de son dispositif médical innovant Artus dans une interview exclusive sur Boursorama. L'entreprise présente les progrès du programme Artus en urologie -
